COMMUNIQUÉS West-GlobeNewswire

Medicana Health Group Conducts Pre-World Cup Health Checks for the Türkiye National Football Team
18/06/2026
As the healthcare sponsor of Türkiye’s National Teams since 2024, Medicana Health Group carried out detailed medical screenings for national football players ahead of their World Cup journey to the United States Photo: [...]
Legend Senior Living Co-CEO Matt Buchanan Named to Senior Housing News' 2026 Executives to Watch List
18/06/2026
WICHITA, Kan., June 18, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living is proud to announce that President and Co-CEO Matt Buchanan has been recognized as one of Senior Housing News' 2026 Executives to Watch , an annual [...]
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
18/06/2026
President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company's vision for transforming women's health SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. ( [...]
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
18/06/2026
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE [...]
SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies
18/06/2026
RANCHO CORDOVA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a collaborative agreement with the Orphan Therapeutics Accelerator (OTXL), a non-profit, biotech focused on completing development [...]
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
18/06/2026
Study results expected to support design and initiation of a pivotal Phase 3 clinical trial in the treatment of metastatic pancreatic cancer OCALA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE [...]
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
18/06/2026
Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki disease is the leading [...]
FamilyWell Health Launches Menopause Hub, Setting the Standard for Behavioral Health in Midlife Care
18/06/2026
Program introduces free clinical guidelines for women’s health providers and a comprehensive behavioral health certification for coaches and clinicians BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- FamilyWell Health , the [...]
New Research from Marius Pharmaceuticals Reveals Major Men's Health Awareness Gap: 65% Have Never Had Their Testosterone Levels Tested
18/06/2026
National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily life RALEIGH, N.C., June 18, 2026 (GLOBE NEWSWIRE) -- New [...]
FDA Approves First Single-Dose Generic Treatment for Influenza
18/06/2026
Drug increases ease of use for patients, in advance of flu season Silver Spring, MD, June 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir [...]
International Myeloma Foundation’s Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress
18/06/2026
Quadruplet Dara-KRd combination demonstrates high rates of response in high-risk smoldering myeloma patients similar to that observed in NDMM; MRD negativity maintained in nearly two-thirds of patients, with median [...]
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
18/06/2026
Designation highlights significant regulatory milestone and provides a potential pathway to seven years of U.S. market exclusivity LA JOLLA, CA, June 18, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” [...]
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
18/06/2026
Company announces name change to SRX Global in conjunction with transaction closing Company’s stock to remain trading on the NYSE American (“NYSE”) under ticker symbol “SRXH” NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE [...]
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
18/06/2026
K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen’s expanded stake and exclusive Asia-Pacific agency [...]
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
18/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding its recent fundraise from [...]
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced [...]
Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring
18/06/2026
New milestone delivers repeatable stress and behavioral metrics, AI-assisted summaries, and longitudinal per-subject tracking — on the same pipeline headed for wearable check-ins MELBOURNE, Fla., June 18, 2026 (GLOBE [...]
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
18/06/2026
Type A Meeting Scheduled with FDA to Potentially Clarify Path to GTx-104 NDA Resubmission Phase 3 STRIVE-ON Safety Trial Data Presented at Multiple Medical Conferences Company Continues Disciplined Pre-Commercial [...]

Pages